Subscribe
Be the first with the news that moves the market- Predictmedix (PMED) has closed a non-brokered private placement for total gross proceeds of $612,500
- The company issued 12,250,000 units at a price of $0.05 per unit
- The company’s common shares are trading on the Frankfurt Stock Exchange under the symbol 3QP
- Predictmedix is a provider of rapid health screening and remote patient care solutions
- Predictmedix Inc. (PMED) opened trading at C$0.115
Predictmedix (PMED) has closed a non-brokered private placement for total gross proceeds of $612,500.
The company issued 12,250,000 units at a price of $0.05 per unit. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share for a period of two years at an exercise price of $0.10 per share.
Net proceeds will be used for general operations, including business development and technology upgrades.
All securities issued are subject to a statutory four-month hold period.
The company’s common shares have been accepted for listing on the Frankfurt Stock Exchange, trading under the symbol 3QP.
“We are excited to trade on the Frankfurt Stock Exchange, offering our shareholders increased liquidity as well as enhancing our global visibility,” commented Dr. Rahul Kushwah, Chief Operating Officer at Predictmedix.
“The Frankfurt Stock Exchange is one of the world’s largest trading centres for securities and the largest stock exchange in Germany. We look forward to introducing Predictmedix to European investors.”
Predictmedix is a provider of rapid health screening and remote patient care solutions.
Predictmedix Inc. (PMED) opened trading at C$0.115.
